Controversies in the Use and Periodicity of Mammography as a Screening Method for Breast Cancer

Affiliations

Editorial

Rogério Bonassi Machado. Rev Bras Ginecol Obstet. 2018 Apr.

. 2018 Apr;40(4):169-170.

doi: 10.1055/s-0038-1648218. Epub 2018 May 10.

¹ Department of Gynecology and Obstetrics, Faculdade de Medicina de Jundiaí, Jundiaí, SP, Brazil.

No abstract available

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this work.

1. Miller A B, Wall C, Baines C J, Sun P, To T, Narod S A. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial. BMJ. 2014;348:g366. - PMC - PubMed
1. Moss S M, Wale C, Smith R, Evans A, Cuckle H, Duffy S W. Effect of mammographic screening from age 40 years on breast cancer mortality in the UK Age trial at 17 years' follow-up: a randomised controlled trial. Lancet Oncol. 2015;16(09):1123–1132. - PubMed
1. Miller A B. New York, Oxford: Oxford University Press; 1996. Fundamental issues in screening for cancer; pp. 1433–1452.
1. Esserman L J, Thompson I M, Reid B et al.Addressing overdiagnosis and overtreatment in cancer: a prescription for change. Lancet Oncol. 2014;15(06):e234–e242. - PMC - PubMed
1. Bleyer A, Welch H G. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med. 2012;367(21):1998–2005. - PubMed